Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman Sells 13,815 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 13,815 shares of the stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $16.89, for a total value of $233,335.35. Following the sale, the chief financial officer now owns 1,482,595 shares of the company’s stock, valued at approximately $25,041,029.55. The trade was a 0.92 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.43, for a total value of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Trading Up 2.7 %

NASDAQ ALHC opened at $17.19 on Thursday. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $17.38. The company’s 50-day moving average price is $14.68 and its 200-day moving average price is $12.59. The stock has a market cap of $3.30 billion, a PE ratio of -22.32 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds have recently added to or reduced their stakes in the stock. R Squared Ltd purchased a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $55,000. RiverPark Advisors LLC purchased a new stake in shares of Alignment Healthcare in the 4th quarter worth $106,000. Tower Research Capital LLC TRC grew its position in shares of Alignment Healthcare by 146.7% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after buying an additional 6,286 shares in the last quarter. Ballentine Partners LLC purchased a new position in shares of Alignment Healthcare during the fourth quarter valued at $121,000. Finally, Aigen Investment Management LP purchased a new position in Alignment Healthcare during the 4th quarter valued at about $129,000. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ALHC. JPMorgan Chase & Co. increased their price target on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research report on Thursday, March 6th. Bank of America boosted their target price on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. Stephens restated an “overweight” rating and issued a $17.00 price objective on shares of Alignment Healthcare in a report on Monday, February 24th. Finally, Stifel Nicolaus lifted their target price on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Friday, February 28th. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.